These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21460853)

  • 1. ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.
    Goetz EM; Shankar B; Zou Y; Morales JC; Luo X; Araki S; Bachoo R; Mayo LD; Boothman DA
    Oncogene; 2011 Sep; 30(35):3745-54. PubMed ID: 21460853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence.
    Luo X; Suzuki M; Ghandhi SA; Amundson SA; Boothman DA
    PLoS One; 2014; 9(6):e99983. PubMed ID: 24937130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
    Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
    Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.
    Shahrabani-Gargir L; Pandita TK; Werner H
    Endocrinology; 2004 Dec; 145(12):5679-87. PubMed ID: 15345673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.
    Chesnokova V; Zonis S; Wawrowsky K; Tani Y; Ben-Shlomo A; Ljubimov V; Mamelak A; Bannykh S; Melmed S
    Mol Endocrinol; 2012 Dec; 26(12):2092-103. PubMed ID: 23051594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.
    Fabbro M; Savage K; Hobson K; Deans AJ; Powell SN; McArthur GA; Khanna KK
    J Biol Chem; 2004 Jul; 279(30):31251-8. PubMed ID: 15159397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.
    Ching JK; Luebbert SH; Collins RL; Zhang Z; Marupudi N; Banerjee S; Hurd RD; Ralston L; Fisher JS
    Exp Physiol; 2013 Feb; 98(2):526-35. PubMed ID: 22941977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
    Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
    Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
    Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
    Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
    Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
    Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells.
    Knobel PA; Kotov IN; Felley-Bosco E; Stahel RA; Marti TM
    Neoplasia; 2011 Oct; 13(10):961-70. PubMed ID: 22028621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage.
    Moumen A; Magill C; Dry KL; Jackson SP
    Cell Cycle; 2013 Feb; 12(4):698-704. PubMed ID: 23343766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling.
    Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K
    DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HINT1 tumor suppressor regulates both gamma-H2AX and ATM in response to DNA damage.
    Li H; Balajee AS; Su T; Cen B; Hei TK; Weinstein IB
    J Cell Biol; 2008 Oct; 183(2):253-65. PubMed ID: 18852295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.